Applied Molecular Transport announced the appointment of Liz Bhatt to the newly created position of Chief Business and Strategy Officer. Ms. Bhatt, an executive with a proven track record in business and corporate development, corporate and commercial strategy and operations, joins AMT with over 25 years of experience in strategic and operational roles within the biopharmaceutical industry. Ms. Bhatt was previously chief operating and chief business officer at Achaogen where she led all corporate development and alliance management activities as well as technical operations and manufacturing. In addition, she was a member of the executive team and involved in the company’s key operational activities. Before Achaogen, she spent an 11-year tenure at Gilead Sciences where she held senior positions in corporate development, most recently as vice president, and was responsible for several key corporate transactions across therapeutic areas, including inflammation, liver disease and oncology. Liz also served in senior positions in global commercial strategy for Gilead’s respiratory and antiviral franchises. Earlier in her career, she also held corporate development and strategic planning positions at Maxygen and Eli Lilly.